| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AMICUS THERAPEUTICS, INC. | Director | Common Stock | 72,468 | $450,026 | $6.21 | 05 Jun 2025 | Direct |
| DMC Global Inc. | Director | Common Stock | 48,653 | $409,658 | $8.42 | 14 May 2025 | Direct |
| NEOGENOMICS INC | Director | Common Stock | 44,009 | $338,869 | $7.70 | 01 Jun 2025 | Direct |
| NEOGENOMICS INC | Director | Restricted Stock Unit | 12,254 | $192,878 | $15.74 | 01 Jun 2024 | Direct |
| NEOGENOMICS INC | Director | Restricted Stock Unit | 23,077 | $125,848 | $10.27 | 01 Jun 2025 | Direct |
| NEOGENOMICS INC | Director | Stock Option (Right to Buy) | 16,107 | $89,061 | $10.27 | 01 Jun 2025 | Direct |
| NEOGENOMICS INC | Director | Common Stock | 5,000 | $38,500 | $7.70 | 01 Jun 2025 | M Kelly & B Kelly TTEE Michael and Bonnie Kelly Revocable Trust DTD 05/02/2016 |
| Aprea Therapeutics, Inc. | Director | Common Stock | 4,610 | $16,969 | $3.68 | 30 Jun 2021 | Direct |
| AMICUS THERAPEUTICS, INC. | Director | Stock Options (right to buy) | 74,872 | 05 Jun 2025 | Direct | ||
| Prime Medicine, Inc. | Director | Stock Option (right to buy) | 45,000 | 01 Aug 2025 | Direct | ||
| AMICUS THERAPEUTICS, INC. | Director | Stock Options (right to buy) | 42,467 | 06 Jun 2024 | Direct | ||
| Aprea Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 22,750 | 30 Jun 2021 | Direct | ||
| HOOKIPA Pharma Inc. | Director | Stock Option (Right to Buy) | 20,000 | 30 Jun 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PRME | Prime Medicine, Inc. | 01 Aug 2025 | 8 | $0 | 4 | Director | 05 Aug 2025, 20:43 |
| FOLD | AMICUS THERAPEUTICS, INC. | 05 Jun 2025 | 2 | $0 | 4 | Director | 06 Jun 2025, 16:54 |
| PRME | Prime Medicine, Inc. | 04 Jun 2025 | 1 | $0 | 4 | Director | 05 Jun 2025, 18:13 |
| NEO | NEOGENOMICS INC | 01 Jun 2025 | 4 | $0 | 4 | Director | 03 Jun 2025, 16:08 |
| NEO | NEOGENOMICS INC | 27 May 2025 | 1 | +$38,000 | 4 | Director | 28 May 2025, 16:07 |
| BOOM | DMC Global Inc. | 14 May 2025 | 1 | $0 | 4 | Director | 15 May 2025, 17:11 |
| BOOM | DMC Global Inc. | 26 Feb 2025 | 1 | $0 | 4 | Director | 27 Feb 2025, 17:13 |
| NEO | NEOGENOMICS INC | 10 Aug 2024 | 2 | $0 | 4 | Director | 13 Aug 2024, 16:32 |
| PRME | Prime Medicine, Inc. | 12 Jun 2024 | 1 | $0 | 4 | Director | 14 Jun 2024, 16:59 |
| FOLD | AMICUS THERAPEUTICS, INC. | 06 Jun 2024 | 2 | $0 | 4 | Director | 07 Jun 2024, 19:47 |
| NEO | NEOGENOMICS INC | 01 Jun 2024 | 2 | $0 | 4 | Director | 04 Jun 2024, 16:09 |
| BOOM | DMC Global Inc. | 15 May 2024 | 1 | $0 | 4 | Director | 15 May 2024, 17:25 |
| NEO | NEOGENOMICS INC | 10 Aug 2023 | 2 | $0 | 4 | Director | 14 Aug 2023, 17:40 |
| PRME | Prime Medicine, Inc. | 14 Jun 2023 | 1 | $0 | 4 | Director | 16 Jun 2023, 17:48 |
| FOLD | AMICUS THERAPEUTICS, INC. | 08 Jun 2023 | 2 | $0 | 4 | Director | 12 Jun 2023, 17:40 |
| BOOM | DMC Global Inc. | 10 May 2023 | 1 | $0 | 4 | Director | 10 May 2023, 17:05 |
| PRME | Prime Medicine, Inc. | 19 Oct 2022 | 1 | $0 | 4 | Director | 21 Oct 2022, 16:30 |
| PRME | Prime Medicine, Inc. | 19 Oct 2022 | 0 | $0 | 3 | Director | 19 Oct 2022, 20:07 |
| HOOK | HOOKIPA Pharma Inc. | 30 Jun 2022 | 1 | $0 | 4 | Director | 01 Jul 2022, 16:09 |
| NEO | NEOGENOMICS INC | 10 Jun 2022 | 2 | $0 | 4 | Director | 14 Jun 2022, 20:43 |
| FOLD | AMICUS THERAPEUTICS, INC. | 09 Jun 2022 | 2 | $0 | 4 | Director | 10 Jun 2022, 16:08 |
| BOOM | DMC Global Inc. | 11 May 2022 | 1 | $0 | 4 | Director | 12 May 2022, 20:43 |
| APRE | Aprea Therapeutics, Inc. | 30 Jun 2021 | 2 | $0 | 4 | Director | 01 Jul 2021, 19:07 |
| FOLD | AMICUS THERAPEUTICS, INC. | 10 Jun 2021 | 2 | $0 | 4 | Director | 14 Jun 2021, 19:10 |
| NEO | NEOGENOMICS INC | 02 Jun 2021 | 2 | $0 | 4 | Director | 04 Jun 2021, 19:59 |
| HOOK | HOOKIPA Pharma Inc. | 01 Jun 2021 | 1 | $0 | 4 | Director | 04 Jun 2021, 20:34 |
| BOOM | DMC Global Inc. | 12 May 2021 | 1 | $0 | 4 | Director | 14 May 2021, 17:04 |